印度卫生外交：新特点及其局限. (Chinese)

For a long time, health diplomacy was not an important issue in India’s diplomatic agenda. After the outbreak of COVID-19, India, with its advantage of being the “pharmacy of the world,” has been trying to lead the neighboring cooperation against the epidemic by promoting “vaccine diplomacy” on a global scale and extending traditional medicine and digital public goods. There are four new features in India’s health diplomacy practices: increasing the importance of the health diplomacy, building the India’s image as a “health donor,” broadening effectively the implementation scope of the health diplomacy and strengthening the international propaganda. Although the outbreak of COVID-19 provides an opportunity for India to be a “leader” in global health diplomacy practices, there is still a large gap between India’s strength, capacity and its ambitions as a major power [ABSTRACT FROM AUTHOR]

卫生外交曾长期在印度外交事务中处于较为边缘的位置。 新冠肺炎疫情暴发后，印度凭借其“世界药房”的优势，在全球范围内 推行“疫苗外交”，并以传统医学和数字公共产品为抓手，积极引领周 边抗疫合作。印度的卫生外交呈现出重要性提升、塑造“施惠者”形象、 实施范围有效拓展以及强化国际宣传等特点。尽管新冠肺炎疫情为印度 打造全球卫生外交“引领者”提供了契机，但其实力和能力与大国雄心 抱负之间还存在较大差距。 [ABSTRACT FROM AUTHOR]

Copyright of International Studies / Guoji Wenti Yanjiu is the property of China International Studies Editorial Department and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)